The interaction of clonidine with dopamine-dependent behaviour in rodents
- 1 January 1977
- journal article
- conference paper
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 297 (2) , 133-141
- https://doi.org/10.1007/bf00499922
Abstract
The effect of clonidine on a number of behavioural parameters believed to be expressed through central dopaminergic mechanisms has been studied in rodents. Clonidine (0.06–2 mg/kg) potentiated the circling response to standard doses of both apomorphine (0.25 mg/kg) and amphetamine (3 mg/kg) in mice with unilateral destruction of nigro-neostriatal dopamine nerve terminals. Similarly, clonidine (0.06–2 mg/kg) enhanced the locomotor effect of apomorphine in reserpinised mice. Clonidine (0.5 mg/kg) was without effect on the patterns of stereotyped behaviours induced by the dopamine agonist apomorphine (0.1–5 mg/kg) in the rat. Unilateral intrastriatal injections of clonidine (5–100 μg) caused no discernable behavioural effects in rats. Injection of apomorphine (10 μg) bilaterally into the region of the nucleus accumbens of the rat resulted in a hyperactive response, while bilateral injection of clonidine (50 μg) into this region caused marked sedation, thus mimicking the effects of these drugs on motor activity when administered systemically. Combinations of systemic or nucleus accumbens apomorphine and clonidine resulted in potentiated stereotypy and prolonged hyperactivity responses. Clonidine (0.5 mg/kg) potentiated the cataleptic effect of the dopamine antagonist haloperidol (0.1–2 mg/kg) in rats. Clonidine therefore potentiated those behavioural responses exhibiting a locomotor component (viz. circling and hyperactivity), but was without effect on stereotypy. The potentiation of catalepsy induced by clonidine may be explained in non-specific sedatory terms. It is apparent that clonidine acts through a secondary neurone system which modifies the effects of dopamine receptor stimulation, although the exact site of this interaction is not clear. The tentative conclusion might be that clonidine inhibits 5-HT neuronal activity, and the possible relationships between 5-HT and NA and dopamine are discussed.This publication has 37 references indexed in Scilit:
- Possible involvement of central histamine H2-receptors in the hypotensive effect of clonidineNature, 1976
- Effect of the norepinephrine receptor stimulating agent ?clonidine? on the turnover of 5-hydroxytryptamine in some areas of the rat brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975
- Serotonergic involvement with neuroleptic catalepsyNeuropharmacology, 1975
- Circling behaviour produced by unilateral lesions in the region of the locus coeruleus in ratsBrain Research, 1975
- The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in ratsNeuropharmacology, 1974
- Involvement of α-receptors in clonidine-induced inhibition of transmitter release from central monoamine neuronesNeuropharmacology, 1973
- Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: Effects of apomorphine, l-DOPA, amantadine, amphetamine and other psychomotor stimulantsNeuropharmacology, 1973
- Cholinergic- and neuroleptic-induced catalepsy: Modification by lesions in the caudate-putamenNeuropharmacology, 1971
- Evidence for a central noradrenaline receptor stimulation by clonidineLife Sciences, 1970
- Aminergic Systems in Basal Ganglia Associated with Stereotyped Hyperactive Behavior and CatalepsyBrain, Behavior and Evolution, 1968